SemiconductorsLOT 261122 · 3 min read

Marvell Draws a $190 Buy Call on Lumentum Lasers and AI Optics

A Seeking Alpha analyst sets a $190 Buy target on Marvell, arguing the Lumentum merger secures scarce AI-optics lasers behind a $20B FY2028 revenue goal after the stock fell from $287.

By Sophie Lindqvist649 words

Key takeaways

  1. Analyst Buy rating on Marvell with a $190 price target; stock closed at $287.01 on October 6 Investor Day.
  2. Marvell targets $20 billion revenue in fiscal 2028, a doubling over two years.
  3. Lumentum shareholders would receive one-third of the combined company for 29% of revenue and 31% of operating profit.
  4. Stated risks: failed deal, laser supply glut, or a cut to the revenue target; margin pressure from customer competition.
  5. Author discloses no positions and no planned trades within 72 hours.
Marvell: Buy The Selloff As It Moves Deeper Into AI Optics
Marvell: Buy The Selloff As It Moves Deeper Into AI Optics — danielkirsch / pixabay

Marvell Technology (MRVL) carries a $190 price target and a Buy rating from a Seeking Alpha analyst, after the stock fell sharply from the $287.01 close recorded at its October 6 Investor Day. The analyst argument rests on one central claim: the pending Lumentum deal secures a scarce laser supply that AI networking cannot do without.

What did Marvell promise investors?

Six weeks before the article, Marvell told investors its revenue would more than double over the next two years. The commitment came at the company's Investor Day on October 6. The stock closed at $287.01 that day. It has fallen since, and the analyst reads the selloff as an entry point rather than a warning.

The revenue roadmap is specific. Marvell targets $20 billion in fiscal 2028 revenue. The analyst attributes that figure to custom-chip programs with major cloud customers. The $190 target itself rests on next-year earnings, not the two-year horizon. That distinction matters. A target built on nearer-term earnings is less exposed to roadmap slippage, but it also captures less of the promised doubling if it arrives.

A caveat follows every promise here. The $20 billion figure is a company target, not a booked order. The article does not say how much of it is covered by binding commitments from the cloud customers involved.

What does the Lumentum deal actually change?

The proposed merger terms are the article's most concrete numbers. Lumentum shareholders would receive one-third of the combined company. In exchange, Lumentum brings a business contributing 29 percent of revenue and 31 percent of operating profit, with faster growth than the rest.

The analyst's logic is supply-chain driven. Lasers for AI optics are scarce, and ownership of that supply de-risks Marvell's AI networking business. The deal, in this reading, is not diversification. It is vertical integration aimed at a bottleneck.

The ownership math invites scrutiny, and the analyst acknowledges it implicitly. One-third of the combined entity is a large price for a business under a third of combined revenue. The faster growth rate is the justification offered. Growth rates are projections. The article does not quantify them.

What could break the thesis?

The analyst lists three failure conditions. Each deserves weight equal to the Buy rating:

  • A failed or restricted deal. Regulatory obstruction would leave Marvell without the laser supply the whole case depends on.
  • A laser supply glut. Scarcity is the premise; abundance would collapse it.
  • A cut to the $20 billion fiscal 2028 revenue target.

A fourth pressure appears without a number attached: customer competition squeezes margins. Marvell's largest custom-chip customers are building their own silicon capabilities. The article names the risk but does not size it.

How solid is the underlying disclosure?

The author states no position in any company mentioned and no plans to initiate one within 72 hours. The article was written without compensation beyond Seeking Alpha's standard arrangement, and the author claims no business relationship with any company named. Seeking Alpha notes its analysts include both professional and individual investors, who may not be licensed or certified by any institute or regulatory body.

That disclosure cuts both ways. Independence removes one conflict. It does not add institutional rigor. The thesis is a single-author view, built on company targets and deal terms that remain subject to approval.

The numbers that survive stress-testing are these: a $190 target, a $287.01 pre-selloff close, an October 6 investor event, a $20 billion fiscal 2028 revenue goal, one-third ownership for Lumentum holders, and a contributed business worth 29 percent of revenue and 31 percent of operating profit. Everything else in the piece is directional.

The commercial question now is whether the deal closes and whether the doubling holds. If both land, the analyst argues, the selloff was the error, not the roadmap.

seekingalpha.com (Source)

Filed under

Share this article:

More from Sophie Lindqvist

Sophie Lindqvist

Show full bio

News editor covering money, funding and market shifts around Semiconductors, chip manufacturing, hardware, AI compute at Chip Dispatch.

1,238 articles

Read also

« Previous article